Exciting insights into the role of ROR1 in CLL
Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia
How does an understanding of the microenvironment aid research in CLL?
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?